Johnson and Johnson has smaller profit in second quarter

Johnson and Johnson, American multinational pharmaceutical and personal care products, posted a net profit of $ 4 billion in the second quarter of this year, a fall of 11.5% over the same period to 2015.
Revenues totaled $ 18.48 billion between April and June this year, an increase of 3.9% compared to the same interval in 2015.
Among the highlights of the second quarter, the company points to the completion of the acquisition of trademark against diaper rash ointments Hipoglós, Procter & Gamble (P & G) announced to the market in March.
Among the priorities of the year, the company claims that should continue accelerating growth in the areas of innovation and expanding the market leadership position in some segments, as in baby care products and skin.
Johnson & Johnson also raised the sales forecast in 2016, the range of US $ 71.2 billion to $ 71.9 billion, to a range of $ 71.5 billion by $ 72.2 billion.